Literature DB >> 963344

The vasodilator actions of isoprenaline, histamine, prostaglandin E2, glucagon and secretin on the hepatic arterial vascular bed of the dog.

P D Richardson, P G Withrington.   

Abstract

The sympathetically-innervated arterial vascular bed of the dog's liver was perfused from a femoral artery. Arterial blood flow and perfusion pressure were measured continuously, and the hepatic arterial vascular resistance calculated. The preparation provided a means of assessing hepatic arterial vasodilatation quantitatively. 2 Isoprenaline, histamine, prostaglandin E2, glucagon and secretin were injected intra-arterially and all evoked dose-dependent vasodilatation of the hepatic arterial vascular bed. 3 The maximum reduction in the calculated hepatic arterial vascular resistance of 37-38% was the same for each of the five substances. 4 Comparisons on a weight basis revealed that prostaglandin E2 was the most potent, followed in potency order by secretin, isoprenaline, histamine and glucagon. 5 Comparisons on a molar basis showed that secretin and prostaglandin E3 were intrinsically considerably more potent than isoprenaline, histamine or glucagon. 6 The onset of the vasodilatator responses to secretin, isoprenaline, histamine and prostaglandin E2, was rapid, and the duration of their actions was brief. 7 The onset of the vasodilator effects of glucagon was slow and its duration of action very prolonged. 8 The implications of these observations with respect to the physiological control of the hepatic arterial vascular bed of the dog are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963344      PMCID: PMC1667031          DOI: 10.1111/j.1476-5381.1976.tb10388.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  HEPATIC CIRCULATION AND HEPATIC FUNCTION DURING ANAESTHESIA AND SURGERY.

Authors:  A GALINDO
Journal:  Can Anaesth Soc J       Date:  1965-05

2.  The control of the hepatic arterial circulation.

Authors:  H B TORRANCE
Journal:  J Physiol       Date:  1961-09       Impact factor: 5.182

3.  Autonomic vasomotor responses in the canine hepatic arterial and venous beds.

Authors:  H D Green; L S Hall; J Sexton; C P Deal
Journal:  Am J Physiol       Date:  1959-01

4.  Continuous recording of acid gastric secretion in the rat.

Authors:  M N GHOSH; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1958-03

5.  Evidence that induced histamine is an intrinsic regulator of the microcirculatory system.

Authors:  R W SCHAYER
Journal:  Am J Physiol       Date:  1962-01

6.  The nature of the vaso-dilator constituents of certain tissue extracts.

Authors:  C H Best; H H Dale; H W Dudley; W V Thorpe
Journal:  J Physiol       Date:  1927-03-15       Impact factor: 5.182

7.  On the local reactions of the arterial wall to changes of internal pressure.

Authors:  W M Bayliss
Journal:  J Physiol       Date:  1902-05-28       Impact factor: 5.182

8.  The mechanism of pancreatic secretion.

Authors:  W M Bayliss; E H Starling
Journal:  J Physiol       Date:  1902-09-12       Impact factor: 5.182

Review 9.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

Review 10.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

View more
  13 in total

1.  Responses of the hepatic arterial vascular bed of the dog to intra-arterial injections of noradrenaline, adrenaline and phenylephrine: the role of beta-adrenoceptors [proceedings].

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

2.  Responses of the sympathetically-innervated hepatic arterial vascular bed of the dog to intra-arterial injections of dopamine [proceedings].

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

4.  Studies on the mechanism of action of glucagon in strips of rabbit renal artery.

Authors:  G Gagnon; D Regoli; F Rioux
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

5.  Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog.

Authors:  P D Richardson; P G Withrington
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

6.  The effects of intra-arterial and intraportal injections of histamine on the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog [proceedings].

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

7.  Responses of the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog to histamine and 5-hydroxytryptamine.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

8.  The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

9.  The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog: marked tachyphylaxis to angiotensin.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

10.  Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.

Authors:  T K Daneshmend; M D Ene; G Parker; C J Roberts
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.